ARVN Sees Landmark PROTAC Approval and Revenue Surge as Pipeline Advances Toward Major Clinical Milestones
Market Chameleon (Tue, 4-Aug 11:18 AM)
Arvinas Secures First PROTAC Approval and Delivers Landmark Revenue in Q2 2026—Multiple Clinical Milestones Ahead
Market Chameleon (Tue, 4-Aug 8:29 AM)
